FDA-cleared CES devices are prescription-only cranial electrotherapy stimulation units authorized to treat anxiety and insomnia under the agency’s Class II 510(k) pathway. As of December 2025, one device, the Flow FL-100, also holds a Class III Premarket Approval for depression. Every other indication a clinician might use one for, including pain or PTSD, is off-label.
What the FDA Has Authorized CES Devices to Treat
Two indications can reach the market through the simpler 510(k) clearance route: anxiety and insomnia. Manufacturers holding 510(k) clearance may legally market their devices only for those uses, and promoting a CES device for any condition outside its clearance violates federal law.1Federal Register. Neurological Devices; Reclassification of Cranial Electrotherapy Stimulator Devices Intended To Treat Anxiety and/or Insomnia
Depression is treated differently. The FDA found the evidence for CES in depression weaker than for anxiety and insomnia, so it kept depression in Class III, requiring the full Premarket Approval process. For years no manufacturer cleared that bar. On December 8, 2025, the FDA approved the Flow FL-100 from Flow Neuroscience, making it the first CES device with PMA approval specifically for depression.2U.S. Food and Drug Administration. Summary of Safety and Effectiveness Data – Flow FL-100
Off-label prescribing is a separate matter. Once a device is on the market, a clinician can prescribe it for other conditions. The Department of Veterans Affairs, for example, has authorized its practitioners to prescribe CES for anxiety, insomnia, depression, PTSD, and headache.3Department of Veterans Affairs HSR&D. The Effectiveness and Risks of Cranial Electrical Stimulation for the Treatment of Pain, Depression, Anxiety, PTSD, and Insomnia: A Systematic Review The line the FDA draws is on marketing, not prescribing: your doctor can order a CES device off-label, but the manufacturer cannot advertise it that way.
Which CES Devices Hold FDA Authorization
Several manufacturers hold active 510(k) clearances for anxiety and insomnia. The best known is the Alpha-Stim line from Electromedical Products International, one of the longest-established CES brands. The CES Ultra from Neuro-Fitness LLC is another. The Cervella from Innovative Neurological Devices LLC received its 510(k) clearance in March 2019.4U.S. Food and Drug Administration. 510(k) Premarket Notification for Cervella Cranial Electrotherapy Stimulator (K182311)
For depression, the Flow FL-100 stands alone with PMA approval as of early 2026. Any other manufacturer wanting to sell a CES device for depression will need its own PMA or an FDA-permitted equivalence pathway to the Flow device.2U.S. Food and Drug Administration. Summary of Safety and Effectiveness Data – Flow FL-100
You can verify any device’s current status through the FDA’s 510(k) database at accessdata.fda.gov.
510(k) Clearance vs. PMA Approval
The two labels sound similar and are not. A 510(k) clearance means the manufacturer showed the FDA the device is substantially equivalent to a predicate product already on the market. A PMA means the FDA independently reviewed clinical trial data and affirmatively approved the device as safe and effective.5U.S. Food and Drug Administration. Device Approvals and Clearances For CES, that is why anxiety and insomnia devices reach the market more readily while depression required a decade-plus clinical evidence build.
Class II CES devices also carry special controls under 21 CFR 882.5800: clinical testing summaries, biocompatibility documentation, electrical safety testing, and specific labeling that includes warnings about headaches and dizziness and instructions for electrode placement and session length.6eCFR. 21 CFR 882.5800 – Cranial Electrotherapy Stimulator
How to Get a CES Device
You need a prescription. Every CES device is classified as prescription-only, whether it is cleared for anxiety, cleared for insomnia, or approved for depression.1Federal Register. Neurological Devices; Reclassification of Cranial Electrotherapy Stimulator Devices Intended To Treat Anxiety and/or Insomnia Written authorization has to come from a licensed clinician whose scope of practice includes ordering medical devices: a physician, psychiatrist, physician assistant, or nurse practitioner. With prescription in hand, you order from the manufacturer or an authorized distributor. Your prescriber should assess whether CES fits your condition before signing.
Cost and Insurance
Plan on paying out of pocket. The Alpha-Stim AID retails for roughly $880, and the Alpha-Stim M, which adds microcurrent electrical therapy for pain, runs around $1,360. The Cervella has historically been priced in the $250 to $300 range. Prices change.
Private insurance generally does not cover CES. Most insurers classify it as investigational. Medicare has no broad national coverage policy, so reimbursement depends on local determinations. The VA is the notable exception: veterans may be able to obtain a device through a VA provider given the department’s authorization to prescribe CES for several conditions.
Because CES devices are FDA-cleared prescription medical devices, they may qualify as eligible expenses under an HSA, FSA, or HRA. Check with your plan administrator before you buy.
Safety and Who Should Not Use CES
Most side effects reported in clinical use are mild and local: tingling, pulsing, or stinging at the electrode sites, and skin irritation on or around the ears. Some users get headaches, dizziness, or brief visual flickering during a session. Drowsiness is common, which tracks with a device often used at bedtime.7NCBI Bookshelf. Table 3, Adverse Events of CES – The Effectiveness and Risks of Cranial Electrical Stimulation
Serious events are rare but documented. In one depression trial, four patients on active CES experienced significant worsening of depressive symptoms and two required hospitalization.7NCBI Bookshelf. Table 3, Adverse Events of CES – The Effectiveness and Risks of Cranial Electrical Stimulation FDA-required labeling reflects this by warning that physicians should monitor patients for signs of worsening.6eCFR. 21 CFR 882.5800 – Cranial Electrotherapy Stimulator
CES is contraindicated if you have an implanted pacemaker or defibrillator, because the current can interfere with the sensing function of cardiac devices.8Alpha-Stim. Indications and Risks Safety during pregnancy has not been established, and clinical trials routinely exclude pregnant participants.9ClinicalTrials.gov. Efficacy of Cranial Electrotherapy Stimulation (CES) for the Treatment of Major Depressive Disorder Talk to your doctor first if you have any implanted electronic device or a history of seizures.